Zeitschriftenaufsatz
|
2018
Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.
Autor:in
Slavic, Svetlana; Andrukhova, Olena; Ford, Kristopher; Handschuh, Stephan; Latic, Nejla; Reichart, Ursula; Sasgary, Soleman; Bergow, Claudia; Hofbauer, Lorenz C; Kostenuik, Paul J; Erben, Reinhold G
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Schlagwörter
Animals; Cytokines; Hematopoietic Stem Cells; Male; Mesenchymal Stem Cells; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Infarctiontherapy; Myocytes, Cardiac; Osteoprotegerin; RANK Ligandantagonists & inhibitors; Receptor Activator of Nuclear Factor-kappa B; Reperfusion Injury
Dokumententyp
Originalarbeit
CC Lizenz
CCBY
Open Access Type
Hybrid
ISSN/eISSN
0946-2716 -
10.1007/s00109-018-1641-x
WoS ID
PubMed ID